EUVIMEDEUVIMED entdecken
Crossref

Risk factors of posterior reversible encephalopathy syndrome in patients with preeclampsia or eclampsia: A retrospective review

Demir Tulin Gesoglu, Cekic Murat, Agircan Dilek, Ethemoglu Ozlem, Sak Sibel

Ideggyógyászati szemle · 2024

DOI: 10.18071/isz.77.0247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ideggyógyászati szemle, 2024. Verfasst von Demir Tulin Gesoglu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harran University, Faculty of Medicine Department of Neurology, Sanliurfa, Turkey. Hauptthemen laut MEDLINE: Posterior Leukoencephalopathy Syndrome, Pre-Eclampsia, Eclampsia. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose – Posterior reversible encephalopathy syndrome (PRES) is characterized by vasogenic edema, usually reversible, with the prominent involvement of the parietal and occipital lobes. The exact etiopathogenesis leading to PRES is unknown. Because signs of eclampsia and preeclampsia in neuroimaging often overlap and manifest as PRES, we aimed to evaluate whether demographic, clinical, and laboratory parameters predict PRES in patients with preeclampsia or eclampsia. Methods – 213 pre-eclampsia or eclampsia patients with cranial imaging were retrospectively examined. We recorded the patients’ demographic information, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), hemogram, biochemical indicators, clinical symptoms, and imaging features. Results – Of all patients, 69% (n = 147) had preeclampsia while 31% (n = 66) had eclampsia, and 24.4% (n = 53) were diagnosed with PRES. The mean age of patients who developed PRES was 25.81 ± 6.07 years and thus significantly less than that of patients who did not develop PRES (p = .000). Patients with PRES had significantly higher mean SBP (p = .015), DBP (p = .009), and MAP (p = .003) than patients without PRES, along with significantly higher aspartate aminotransferase (ASAT; p = .001), alanine aminotransferase (ALAT; p = .001) blood urea nitrogen (BUN; p = .001), white blood cell (WBC; p = .003), neutrophil (p = .001), and hemoglobin (Hb; p = .027) levels, but significantly lower albumin (p = .000) levels. Conclusion – Age, high blood pressure, and BUN, neutrophil, and WBC levels were predictors of the development of PRES in patients with preeclampsia and eclampsia. Early neuroimaging considering those predictors should be performed to diagnose PRES in patients with preeclampsia and eclampsia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Posterior Leukoencephalopathy SyndromePre-EclampsiaEclampsiaHumansFemalePregnancyRetrospective StudiesAdultRisk FactorsBlood Pressure

Stichwörter der Autor:innen

eclampsiahypertensionposterior reversible encephalopathy syndrome (PRES)preeclampsiapregnancy

Autor:innen und Institutionen

  • Harran University, Faculty of Medicine Department of Neurology, Sanliurfa, Turkey.
  • Harran University, Faculty of Medicine Department of Obstetrics and Gynecology, Sanliurfa, Turkey.

Zitieren

APA

Tulin Gesoglu, D., Murat, C., Dilek, A., Ozlem, E., & Sibel, S. (2024). Risk factors of posterior reversible encephalopathy syndrome in patients with preeclampsia or eclampsia: A retrospective review. Ideggyógyászati szemle. https://doi.org/10.18071/isz.77.0247

Vancouver

Tulin Gesoglu D, Murat C, Dilek A, Ozlem E, Sibel S. Risk factors of posterior reversible encephalopathy syndrome in patients with preeclampsia or eclampsia: A retrospective review. Ideggyógyászati szemle. 2024. doi:10.18071/isz.77.0247

BibTeX
@article{TulinGesoglu2024,
  author = {Tulin Gesoglu, Demir and Murat, Cekic and Dilek, Agircan and Ozlem, Ethemoglu and Sibel, Sak},
  title = {Risk factors of posterior reversible encephalopathy syndrome in patients with preeclampsia or eclampsia: A retrospective review},
  journal = {Ideggyógyászati szemle},
  year = {2024},
  doi = {10.18071/isz.77.0247}
}
Kostenlos starten →